Form 8.3 - HORIZON THERAPEUTICS PLC Amendment

Barclays PLC
16 June 2023
 

FORM 8.3 Amendment to Purchase and Sale

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2007 (AS AMENDED)

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES

REPRESENTING 1% OR MORE

1.

KEY INFORMATION

Name of person dealing (Note 1)

Barclays PLC.

Company dealt in

HORIZON THERAPEUTICS PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

$0.001 ordinary shares

Date of dealing

07 Jun 2023

2.

INTERESTS AND SHORT POSITIONS

(a)

Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:

$0.001 ordinary shares


Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities 

1,086,558

0.47%

676,045

0.30%

(2)

Derivatives (other than options):

140,756

0.06%

98,064

0.04%

(3)

Options and agreements to purchase/sell:

1,420,000

0.62%

936,400

0.41%

TOTAL:

2,647,314

1.16%

1,710,509

0.75%

(b)

Interests and short positions in relevant securities of the company, other than the class dealt in

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

(3)

Options and agreements to purchase/sell:

 

 

 

 

TOTAL:

 

 

 

 

3.

DEALINGS (Note 4)

(a)

Purchase and sales

 






Class of relevant Security

Purchase/sale

Number of securities

Price per unit

$0.001 ordinary shares

Purchase

4

                  99.9700 USD

$0.001 ordinary shares

Purchase

12

                  99.6200 USD

$0.001 ordinary shares

Purchase

100

                  99.7700 USD

$0.001 ordinary shares

Purchase

183

                  99.6721 USD

$0.001 ordinary shares

Purchase

208

                 100.0011 USD

$0.001 ordinary shares

Purchase

591

                  99.7697 USD

$0.001 ordinary shares

Purchase

625

                  99.7944 USD

$0.001 ordinary shares

Purchase

1,604

                  99.8086 USD

$0.001 ordinary shares

Purchase

2,073

                  99.6980 USD

$0.001 ordinary shares

Purchase

3,349

                  99.4495 USD

$0.001 ordinary shares

Purchase

3,430

                  99.7522 USD

$0.001 ordinary shares

Purchase

3,538

                  99.6777 USD

$0.001 ordinary shares

Purchase

3,819

                  99.7583 USD

$0.001 ordinary shares

Purchase

5,912

                  99.4400 USD

$0.001 ordinary shares

Purchase

9,526

                  99.6036 USD

$0.001 ordinary shares

Purchase

15,500

                 105.0000 USD

$0.001 ordinary shares

Purchase

18,131

                  99.5307 USD

$0.001 ordinary shares

Sale

4

                  99.9700 USD

$0.001 ordinary shares

Sale

15

                  99.8266 USD

$0.001 ordinary shares

Sale

47

                  99.8600 USD

$0.001 ordinary shares

Sale

100

                  99.9350 USD

$0.001 ordinary shares

Sale

100

                  99.4100 USD

$0.001 ordinary shares

Sale

200

                 100.0100 USD

$0.001 ordinary shares

Sale

384

                  99.8183 USD

$0.001 ordinary shares

Sale

536

                  99.7672 USD

$0.001 ordinary shares

Sale

854

                  99.7719 USD

$0.001 ordinary shares

Sale

1,088

                  99.5147 USD

$0.001 ordinary shares

Sale

1,317

                  99.6680 USD

$0.001 ordinary shares

Sale

1,887

                  99.6843 USD

$0.001 ordinary shares

Sale

1,932

                  99.8305 USD

$0.001 ordinary shares

Sale

2,865

                  99.7536 USD

$0.001 ordinary shares

Sale

8,391

                  99.6137 USD

$0.001 ordinary shares

Sale

8,736

                  99.4400 USD

$0.001 ordinary shares

Sale

24,224

                  99.5785 USD

 
















(b)

Derivatives transactions (other than option transactions)

Product Name

Nature of transaction

Number of relevant securities

Price per unit

 

 

 

 

 
















(c)

Options transactions in respect of existing securities

(i)

Writing, selling, purchasing or varying

Class

 of

 relevant

 security

Product

 description

Writing,

 purchasing,

 selling,

 varying etc

Number

 of

 securities

 to which

 option

 relates

Exercise

 price

 per unit

Type

Expiry

 date

Option

 money

 paid/

 received

 per unit

 

 

 

 

 

 

 

 

 
















(ii)

Exercising

 






Product name

Number of

 securities

Exercise price

 per unit

 

 

 

 
















(d)

Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

Details

Price per unit  (if applicable)

 

 

 

4.

OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing

 and any other person relating to the voting rights of any relevant securities under any option

 referred to on this form or relating to the voting rights or future acquisition or disposal of any

 relevant securities to which any derivative referred to on this form is referenced. If none, this

 should be stated.

NONE

Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:

15 Jun 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection

 

 








SUPPLEMENTAL FORM 8

 








IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL

ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as

appropriate)

OPEN POSITIONS

 







Class of relevant

 security

Product

 Description

Writing,

 purchasing,

 selling,

 varying etc

Number

 of

 securities

 to which

 option

 relates

Exercise

 price

 per unit

Type

Expiry

 date

$0.001 ordinary shares

Put Options

Written

495,500

100

American

16 Jun 2023

$0.001 ordinary shares

Put Options

Written

28,800

095

American

21 Jul 2023

$0.001 ordinary shares

Call Options

Written

-10,600

105

American

18 Aug 2023

$0.001 ordinary shares

Put Options

Written

2,000

085

American

21 Jul 2023

$0.001 ordinary shares

Put Options

Purchased

-250,000

080

American

16 Jun 2023

$0.001 ordinary shares

Put Options

Written

10,200

080

American

18 Aug 2023

$0.001 ordinary shares

Put Options

Written

247,500

105

American

16 Jun 2023

$0.001 ordinary shares

Call Options

Written

-2,000

100

American

21 Jul 2023

$0.001 ordinary shares

Call Options

Written

-2,600

100

American

18 Aug 2023

$0.001 ordinary shares

Put Options

Written

400,000

100

American

18 Aug 2023

$0.001 ordinary shares

Put Options

Written

74,000

090

American

15 Sep 2023

$0.001 ordinary shares

Put Options

Purchased

-544,200

080

American

18 Aug 2023

$0.001 ordinary shares

Put Options

Written

162,000

105

American

21 Jul 2023

$0.001 ordinary shares

Call Options

Written

-10,000

105

American

16 Jun 2023

$0.001 ordinary shares

Put Options

Purchased

-106,800

090

American

21 Jul 2023

$0.001 ordinary shares

Put Options

Purchased

-10,200

100

American

18 Aug 2023

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Barclays (BARC)
UK 100

Latest directors dealings